Jill Hall, MD
Gynecology · Ventura, CANPI 1265607204
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,748 of the $6,283 with a category attached, or 75.6%. Medtronic accounts for 71.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $2,830 and has fallen 64.7% since, to $999 in 2025.
Across 121 payments — averaging $51.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Intuitive Surgical$347
- Axonics, Inc.$329
- Coloplast$210
- Valencia Technologies Corporation$132
- Amarin Pharma, Inc.$125
- plus $660 from 11 others
What the payments were for
- Travel & lodging$1,26620%
- Food & beverage$4,74876%
- Education$2694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 69 | $4,480 |
| Intuitive Surgical | 4 | $347 |
| Axonics, Inc. | 10 | $329 |
| Coloplast | 10 | $210 |
| Valencia Technologies Corporation | 2 | $132 |
| Amarin Pharma, Inc. | 1 | $125 |
| Femselect Inc. | 1 | $117 |
| Smith+Nephew | 3 | $98 |
| Pfizer | 6 | $97 |
| AbbVie | 3 | $80 |
| Astellas Pharma US Inc | 4 | $74 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Boston Scientific | 2 | $47 |
| Johnson & Johnson | 1 | $27 |
| Progenics Pharmaceuticals, Inc. | 1 | $26 |
| Duchesnay USA Incorporated | 1 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,283 in reported general payments places this provider in the 85th percentile of 247 gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 236 | $155,443 |
| MyrbetriqMirabegron | 190 | $103,445 |
| Estradiol | 289 | $16,202 |
| PremarinEstrogens, Conjugated | 20 | $8,460 |
| Mirabegron ErMirabegron | 18 | $7,656 |
| Fosfomycin Tromethamine | 17 | $3,259 |
| Darifenacin ErDarifenacin Hydrobromide | 15 | $1,971 |
| Tolterodine Tartrate ErTolterodine Tartrate | 31 | $1,550 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $1,066 |
| Heparin SodiumHeparin Sodium,porcine | 25 | $796 |
| Solifenacin Succinate | 23 | $754 |
| Ketoconazole | 15 | $580 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 32 | $406 |
| Cephalexin | 43 | $319 |
| Bethanechol Chloride | 22 | $281 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $50 | $155,443236 claims |
| Astellas Pharma US IncMyrbetriq | $74 | $103,445190 claims |
| PfizerPremarin | $97 | $8,46020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 247 gynecology providers in California.
Other gynecology in Ventura
- Bruce LeeMonterey$2.8M
- Barbara Levyla Jolla$719K
- Samar NahasRiverside$132K
- Aarathi CholkeriEl Segundo$128K
- Kelly WrightLos Angeles$119K
- Naphthali AlinsodLaguna Beach$108K
- Albertine OmaniOakland$70K
- Matthew SiedhoffBeverly Hills$67K
- Justin DiedrichAgoura Hills$46K
- Thomas CunninghamMonterey$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.